Impact of Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer


Condition: Breast Cancer, Prostate Cancer

Study Type: Observational

Clinical Trials Identifier NCT 8-digits: NCT07014618

Sponsor: University of Oklahoma

Phase:

Eligibility:

  • Age: minimum 18 Years maximum N/A
  • Gender: All

Inclusion Criteria:

  • Subjects must have histologically or cytologically confirmed Breast or Prostate Cancer.
  • Subjects must be 18 years of age or older. This study requires informed consent by the subject.
  • Subjects must be of African American race, Native American race, or Hispanic ethnicity.
  • Subjects scheduled to undergo RT for Cancer Treatment.
  • Subjects must have the ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:

  • Subjects NOT of African American race, Native American race or Hispanic ethnicity.
  • Subjects WITHOUT histologically/cytologically confirmed Breast or Prostate Cancer.
  • Subjects younger than 18 years old.

View trial on ClinicalTrials.gov